Advertisement
Journal Home
Search for

Articles in Press

Return to articles in press list

Response to deep TMS in depressive patients with previous electroconvulsive treatment

Oded Rosenberg, MDaCorresponding Author Informationemail address, Abraham Zangen, PhDb, Rafael Stryjer, MDa, Moshe Kotler, MDa, Pinhas N. Dannon, MDa

Received 10 May 2009; received in revised form 23 November 2009; accepted 1 December 2009. published online 31 December 2009.
Corrected Proof

Background

The efficacy of transcranial magnetic stimulation (TMS) in the treatment of major depression has already been shown. Novel TMS coils allowing stimulation of deeper brain regions have recently been developed and studied.

Objective

Our study is aimed at exploring the possible efficacy of deep TMS in patients with resistant depression, who previously underwent electroconvalsive therapy (ECT).

Methods

Using Brainsway's deep TMS H1 coil, six patients who previously underwent ECT, were treated with 120% power of the motor threshold at a frequency of 20 Hz. Patients underwent five sessions per week, up to 4 weeks. Before the study, patients were evaluated using the Hamilton depression rating scale (HDRS, 24 items), the Hamilton anxiety scale, and the Beck depression inventory and were again evaluated after 5, 10, 15, and 20 daily treatments. Response to treatment was considered a reduction in the HDRS of at least 50%, and remission was considered a reduction of the HDRS-24 below 10 points.

Results

Two of six patients responded to the treatment with deep TMS, including one who achieved full remission.

Conclusions

Our results suggest the possibility of a subpopulation of depressed patients who may benefit from deep TMS treatment, including patients who did not respond to ECT previously. However, the power of the study is small and similar larger samples are needed.

a The Beer Ya'acov Mental Health Institution, Beer Ya'acov, Israel

b Department of Neurobiology, the Weizmann Institute of Science, Rehovot 76100, Israel

Corresponding Author InformationCorrespondence: Dr. Oded Rosenberg, Beer Ya'acov Mental Health Institution, Derech Hazayit 239, Kfar Shmuel, Moaza Ezorit Gezer 99788, Israel.

 Prof. Dannon and Dr. Rosenberg received an unrestricted educational grant for deep TMS research from Brainsway Company.

 Dr. Zangen is working as a research consultant in Brainsway Company.

PII: S1935-861X(09)00110-7

doi:10.1016/j.brs.2009.12.001

Advertisement